Phase 3 Head and Neck Cancer Trial, Recruiting NCT06026878 Sponsor: Air Force Military Medical University, China Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Phase 3 Head and Neck Cancer Trial, Recruiting

NCT06026878
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 75 years old.
  • You have been diagnosed with a specific type of nasopharyngeal cancer (a cancer at the back of the nose/throat), confirmed by a lab test, at an advanced stage (stage III to IVB).
  • Your doctors have determined that you are suitable for intensive treatment combining radiation and chemotherapy.
  • You are in generally good physical condition and able to carry out normal daily activities (confirm with trial site for exact fitness level required).
  • You have at least one tumor that can be measured on a scan, and your blood counts are within acceptable ranges (including white blood cells, platelets, and hemoglobin).
  • Your kidneys are functioning at a basically normal level, based on blood tests.
  • Your liver is functioning at a basically normal level, based on blood tests.
  • You are willing and able to sign a consent form agreeing to take part.

Who may not be able to join:

  • You have previously received immunotherapy or targeted therapy for your cancer.
  • You have taken part in another interventional clinical trial within the last 30 days.
  • You have a history of another cancer, unless it was a type of skin cancer (basal cell carcinoma) that has been fully cured.
  • You have a history of a condition where your immune system does not work properly from birth.
  • You have another serious uncontrolled health condition, such as heart failure, severe lung, liver, or mental health problems.
  • You are known to have HIV, active hepatitis, or tuberculosis.
  • You have had major surgery within the past 90 days before starting the trial, or have surgery planned.
  • You are allergic to any of the medications used in this trial.
  • You are pregnant or breastfeeding, or you are of childbearing age and are unwilling or unable to use effective contraception during the trial and for at least 6 months after the last treatment (this applies to both men and women).
  • You have received a live vaccine within 30 days of starting the trial.
  • The trial doctor feels, for any reason, that this study is not right for you.
  • You are unwilling to participate or unable to sign the consent form.

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
Air Force Military Medical University, China
Registry
ClinicalTrials.gov
Start date
1 September 2023
Est. completion
30 September 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

overall response rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov